Platelet aggregability and prostacyclin/thromboxane a2 ratio after endoscopic injection sclerotherapy with different sclerosants

H. Yamaga, M. Hashizume, H. Wada, S. Kitano, K. Sugimachi

研究成果: ジャーナルへの寄稿学術誌査読

1 被引用数 (Scopus)

抄録

Platelet aggregability and coagulative and fibrinolytic systems were analyzed with regard to positive effects and for side effects of 5% ethanolamine oleate (EO) versus 5% sodium morrhuate (SM) used for endoscopic injection sclerotherapy (EIS). Twelve patients each were treated with each sclerosant. There was a temporary activation of coagulative and fibrinolytic systems within 1 h in both groups. Platelet aggregability was significantly suppressed to 78.6 ± 8.9% of that before EIS in the EO group, but was activated to 110.0 ± 10.5% in the SM group at 1 h after EIS. The ratio of concentrations of prostacyclin (PGI2) to thromboxane A2 (TXA2) increased int he EO group and decreased in the SM group after EIS. The clinical effect in the SM group after the initial session was weaker than that in the EO group with regard to endoscopic findings at the second session. As change in platelet aggregability after EIS is apparently induced by alterations in the ratio of PGI2/TXA2, there would be related effects concerning the sclerosants.

本文言語英語
ページ(範囲)228-234
ページ数7
ジャーナルEuropean Surgical Research
23
3-4
DOI
出版ステータス出版済み - 1991
外部発表はい

!!!All Science Journal Classification (ASJC) codes

  • 外科

フィンガープリント

「Platelet aggregability and prostacyclin/thromboxane a2 ratio after endoscopic injection sclerotherapy with different sclerosants」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル